Oxford Nanopore Technologies Ltd (ONT) - Total Assets
Based on the latest financial reports, Oxford Nanopore Technologies Ltd (ONT) holds total assets worth GBX565.40 Million GBX (≈ $68.79K USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Oxford Nanopore Technologies Ltd - Total Assets Trend (2012–2025)
This chart illustrates how Oxford Nanopore Technologies Ltd's total assets have evolved over time, based on quarterly financial data. Also see Oxford Nanopore Technologies Ltd (ONT) market capitalisation for the company's overall valuation and market capitalisation.
Oxford Nanopore Technologies Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Oxford Nanopore Technologies Ltd's total assets of GBX565.40 Million consist of 67.5% current assets and 32.5% non-current assets. Review ONT liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 29.1% |
| Accounts Receivable | GBX52.50 Million | 8.4% |
| Inventory | GBX81.50 Million | 13.1% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX55.80 Million | 9.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Oxford Nanopore Technologies Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Oxford Nanopore Technologies Ltd (ONT) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oxford Nanopore Technologies Ltd's current assets represent 67.5% of total assets in 2025, a decrease from 97.0% in 2012.
- Cash Position: Cash and equivalents constituted 29.1% of total assets in 2025, down from 42.2% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 13.1% of total assets.
Oxford Nanopore Technologies Ltd Competitors by Total Assets
Key competitors of Oxford Nanopore Technologies Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Abivax SA
PA:ABVX
|
France | €547.14 Million |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥37.46 Billion |
|
Braveheart Bio, Inc. Common Stock
NASDAQ:BRVE
|
USA | $126.96 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Lifecome Biochemistry Co Ltd
SHE:002868
|
China | CN¥729.16 Million |
|
Pulike Biological Engineering
SHG:603566
|
China | CN¥3.09 Billion |
|
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
|
USA | $423.10 Million |
|
NEWRON PHARMACEUT. EO-20
XETRA:NP5
|
Germany | €40.03 Million |
Oxford Nanopore Technologies Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.52 | 4.79 | 6.76 |
| Quick Ratio | 2.73 | 3.89 | 5.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX256.20 Million | GBX401.60 Million | GBX301.34 Million |
Oxford Nanopore Technologies Ltd - Advanced Valuation Insights
This section examines the relationship between Oxford Nanopore Technologies Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.63 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -16.1% |
| Total Assets | GBX622.50 Million |
| Market Capitalization | $21.17 Million USD |
Valuation Analysis
Below Book Valuation: The market values Oxford Nanopore Technologies Ltd's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Oxford Nanopore Technologies Ltd's assets decreased by 16.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Oxford Nanopore Technologies Ltd (2012–2025)
The table below shows the annual total assets of Oxford Nanopore Technologies Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | GBX622.50 Million ≈ $75.74K |
-16.11% |
| 2024-12-31 | GBX742.05 Million ≈ $90.29K |
-4.51% |
| 2023-12-31 | GBX777.06 Million ≈ $94.55K |
-5.68% |
| 2022-12-31 | GBX823.89 Million ≈ $100.24K |
-2.14% |
| 2021-12-31 | GBX841.87 Million ≈ $102.43K |
+199.37% |
| 2020-12-31 | GBX281.21 Million ≈ $34.22K |
+70.70% |
| 2019-12-31 | GBX164.74 Million ≈ $20.04K |
-5.97% |
| 2018-12-31 | GBX175.19 Million ≈ $21.32K |
+46.84% |
| 2017-12-31 | GBX119.31 Million ≈ $14.52K |
-24.94% |
| 2016-12-31 | GBX158.94 Million ≈ $19.34K |
+46.13% |
| 2015-12-31 | GBX108.77 Million ≈ $13.23K |
+54.72% |
| 2014-12-31 | GBX70.30 Million ≈ $8.55K |
+2.08% |
| 2013-12-31 | GBX68.87 Million ≈ $8.38K |
+32.58% |
| 2012-12-31 | GBX51.95 Million ≈ $6.32K |
-- |
About Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more